Investors
Events & Presentations
Financial & Filings
Stock Information
Investor FAQs
Contact Us
Newsroom
Areas of Focus
Cardiometabolic
Severe Hypertriglyceridemia
Dyslipidemia
Cardiovascular Disease
Obesity
Pulmonary
Inflammatory Pulmonary Diseases
Idiopathic Pulmonary Fibrosis
Pipeline
Science & Innovation
Partnerships
Publications
Clinical Trials
Patients & Caregivers
What is RNAi?
Expanded Access Programs
FCS Patient Insights
About
Leadership Team
Corporate Governance
Careers
Job Openings
Investors
Events & Presentations
Financial & Filings
Stock Information
Investor FAQs
Contact Us
Newsroom
Publications
Home
/
Science & Innovation
/
Publications
Filter by
Year Published
2024
2023
2022
2021
2020
2019
2018
2017
2015
2013
2012
2011
2010
2007
2006
2005
2004
2003
2002
Selections
Clear Filters
HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
Read More
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis
Read More
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis
Read More
Pharmacokinetics, Safety, and Tolerability of the siRNA JNJ-73763989 in Healthy Chinese Adult Participants, Clinical Pharmacology in Drug Development
Read More
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
Read More
Plasma and Liver Pharmacokinetics of the N-Acetylgalactosamine Short Interfering RNA JNJ-73763989 in Recombinant Adeno-Associated-Hepatitis B Virus-Infected Mice
Read More
Pharmacokinetics, Pharmacodynamics, and Tolerability of Olpasiran in Healthy Japanese and Non-Japanese Participants: Results from a Phase I, Single-dose, Open-label Study
Read More
Study design and rationale for the Olpasiran trials of Cardiovascular Events And lipoproteiN(a) reduction-DOSE finding study (OCEAN(a)-DOSE)
Read More
Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency
Read More
Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHB
Read More
Prev
1
2
3
4
5
...
7
Next
